Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,334,429
-$322,878 QoQ
Shares Held
138,473
+6.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#766
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. PFE ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
This page
|
138,473 | $3,334,429 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,334,429 | 138,473 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $3,657,307 | 130,246 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,078,710 | 123,643 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,910,325 | 114,220 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $291,122 | 12,010 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $2,865,067 | 113,065 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,761,693 | 104,097 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $3,510,827 | 121,314 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $3,304,941 | 118,118 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,708,953 | 133,656 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,487,562 | 121,138 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $3,749,469 | 113,038 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $4,061,429 | 110,726 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $5,924,731 | 145,214 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $7,370,925 | 143,851 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,071,043 | 138,735 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $6,316,713 | 120,479 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $6,076,813 | 117,381 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,846,067 | 99,002 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,642,430 | 84,688 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,326,131 | 84,937 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $2,540,446 | 70,120 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,721,951 | 73,946 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $2,635,274 | 71,806 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,602,658 | 79,592 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $2,025,241 | 62,048 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||